136 related articles for article (PubMed ID: 19224551)
1. Prognostic impact of mitotic index of proliferating cell populations in cervical cancer patients treated with carbon ion beam.
Suzuki Y; Oka K; Ohno T; Kato S; Tsujii H; Nakano T
Cancer; 2009 May; 115(9):1875-82. PubMed ID: 19224551
[TBL] [Abstract][Full Text] [Related]
2. The phase I/II clinical study of carbon ion therapy for cancer of the uterine cervix.
Nakano T; Suzuki M; Abe A; Suzuki Y; Morita S; Mizoe J; Sato S; Miyamoto T; Kamada T; Kato H; Tsujii H
Cancer J Sci Am; 1999; 5(6):362-9. PubMed ID: 10606478
[TBL] [Abstract][Full Text] [Related]
3. Correlation of cervical carcinoma c-erb B-2 oncogene with cell proliferation parameters in patients treated with radiation therapy for cervical carcinoma.
Nakano T; Oka K; Ishikawa A; Morita S
Cancer; 1997 Feb; 79(3):513-20. PubMed ID: 9028362
[TBL] [Abstract][Full Text] [Related]
4. Carbon beam therapy overcomes the radiation resistance of uterine cervical cancer originating from hypoxia.
Nakano T; Suzuki Y; Ohno T; Kato S; Suzuki M; Morita S; Sato S; Oka K; Tsujii H
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2185-90. PubMed ID: 16609033
[TBL] [Abstract][Full Text] [Related]
5. A ratio of apoptosis to mitosis, proliferation pattern and prediction of radiotherapy response in cervical carcinoma.
Gasinska A; Urbanski K; Gruchala A; Biesaga B; Kojs Z
Neoplasma; 2002; 49(6):379-86. PubMed ID: 12584585
[TBL] [Abstract][Full Text] [Related]
6. Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer.
Mizoe JE; Tsujii H; Kamada T; Matsuoka Y; Tsuji H; Osaka Y; Hasegawa A; Yamamoto N; Ebihara S; Konno A;
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):358-64. PubMed ID: 15380567
[TBL] [Abstract][Full Text] [Related]
7. High growth fraction at 9 grays of radiotherapy is associated with a good prognosis for patients with cervical squamous cell carcinoma.
Oka K; Suzuki Y; Nakano T
Cancer; 2000 Oct; 89(7):1526-31. PubMed ID: 11013367
[TBL] [Abstract][Full Text] [Related]
8. EGFR LI and Ki-67 LI are independent prognostic parameters influencing survivals of surgically treated squamous cell lung cancer patients.
Niemiec J; Kolodziejski L; Dyczek S
Neoplasma; 2005; 52(3):231-7. PubMed ID: 15875085
[TBL] [Abstract][Full Text] [Related]
9. Prognostic values of proliferating cell nuclear antigen (PCNA) and Ki-67 for radiotherapy of oesophageal squamous cell carcinomas.
Okuno Y; Nishimura Y; Kashu I; Ono K; Hiraoka M
Br J Cancer; 1999 May; 80(3-4):387-95. PubMed ID: 10408843
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic p105 index is an accurate mitotic index, but is not related to prognosis in cervical carcinoma.
Oka K; Nakano T; Arai T
Arch Pathol Lab Med; 1994 May; 118(5):506-9. PubMed ID: 7910727
[TBL] [Abstract][Full Text] [Related]
11. Assessment of proliferation index with MIB-1 as a prognostic factor in radiation therapy for cervical cancer.
Suzuki M; Tsukagoshi S; Saga Y; Ohwada M; Sato I
Gynecol Oncol; 2000 Nov; 79(2):300-4. PubMed ID: 11063661
[TBL] [Abstract][Full Text] [Related]
12. Correlation between survivin expression and locoregional control in cervical squamous cell carcinomas treated with radiation therapy.
Suzuki Y; Oka K; Yoshida D; Shirai K; Ohno T; Kato S; Tsujii H; Nakano T
Gynecol Oncol; 2007 Mar; 104(3):642-6. PubMed ID: 17141299
[TBL] [Abstract][Full Text] [Related]
13. Interstitial fluid pressure as a prognostic factor in cervical cancer following radiation therapy.
Yeo SG; Kim JS; Cho MJ; Kim KH; Kim JS
Clin Cancer Res; 2009 Oct; 15(19):6201-7. PubMed ID: 19773374
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical prediction of radiation response and local control in radiation therapy for cervical cancer.
Nakano T; Oka K; Ishikawa A; Morita S
Cancer Detect Prev; 1998; 22(2):120-8. PubMed ID: 9544432
[TBL] [Abstract][Full Text] [Related]
15. [Some kinetic characteristics of cervical cancer].
Zharinov GM; Pozharisskiĭ KM; Vinokurov VL; Neklasova NIu; Mironovskaia NV; Kuznetsova ME; Tarkova AB
Vopr Onkol; 2009; 55(2):196-200. PubMed ID: 19514375
[TBL] [Abstract][Full Text] [Related]
16. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
17. [Radiotherapeutic effect and prognosis of bulky exophytic cervical cancer].
Zheng XK; Chen LH; Li J
Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):332-4, 338. PubMed ID: 15772006
[TBL] [Abstract][Full Text] [Related]
18. Mixed small cell carcinomas of the uterine cervix: prognostic impact of focal neuroendocrine differentiation but not of Ki-67 labeling index.
Horn LC; Hentschel B; Bilek K; Richter CE; Einenkel J; Leo C
Ann Diagn Pathol; 2006 Jun; 10(3):140-3. PubMed ID: 16730307
[TBL] [Abstract][Full Text] [Related]
19. Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer.
Yamashita H; Murakami N; Asari T; Okuma K; Ohtomo K; Nakagawa K
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1165-72. PubMed ID: 19101092
[TBL] [Abstract][Full Text] [Related]
20. Proliferation to apoptosis ratio as a prognostic marker in adenocarcinoma of uterine cervix.
Leung TW; Xue WC; Cheung AN; Khoo US; Ngan HY
Gynecol Oncol; 2004 Mar; 92(3):866-72. PubMed ID: 14984954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
